INTRODUCTION
To develop a radloimmunoassay (RIA) for measuring steroids, antibodies for the assay are produced using a steroid hapten-carrier protein conjugate.
The resulting antibodies often recognize and demonstrate high affinity binding to both the steroid and the chemical bridge through which the hapten was attached to the carrier protein.
This phenomena is referred to as bridge-binding (I-8). Use of 1251 as the radionuclide to produce a labeled trace for the RIA requires that the iodinated functional group, phenol or imidazole, be attached to the steroid with a chemical bridge.
However, if the label-bridge is homologous to the conjugate-bridge, the antibodies will have a higher affinity for the label than the native steroid. Consequently, the amount of steroid required to displace the radiolodlnated steroid will be so great that the standard curve will shift to the right resulting in a substantial loss of sensitivity. In addition, the slope of the curve will be very shallow causing a loss of precision.
~~oxx~ Recently we reported (I) on a procedure for reducing bridgebinding in a RIA for androstenedione (9) . By using both a succinyl ester linkage (-02CCH2CH2CO2-steroid) and an ether linkage (-NHCOCH20-steroid) attached to the 19 position of androstenedione, we were able to obtain a very sensitive and precise RIA. Unfortunately, the antisera, which was produced in sheep, was not very specific. The assay had a high crossreactivity towards closely related steroids, such as 5e-androstanedione, dehydroepiandrosterone and androsterone. Later, Racet al reported (10) a RIA using a tritiated label and rabbit antibody against a bovine serum albumin-androstenedione conjugate (BSA-NHCOCH20-19-androstenedione) which was structurally identical to one that we had used (I). Although their rabbit antibody was more specific than the sheep antisera, it exhibited high nonspecificity to 5a-androstanedlone and crossreactivity of about 2% or more to testosterone, dehydroepiandrosterone and androsterone.
We wish to report a RIA that employs sheep antibody against androstenedione linked to BSA with an ether bridge at the 118 position of the steroid (BSA-NHCOCH20-11B-androstenedione) and a label that has an ester bridge (1251-phenol-CH2C02-11 6-androstenedione ). The resulting assay is very sensitive and precise. In addition, the crossreactlvities of the antibody against testosterone, androsterone and dehydroepiandrosterone are at least ten-fold less than those reported by Rao et el (10) .
MATERIALS
Na[125I] (carrier free) was obtained from New England Nuclear.
testosterone, 5~-dihydrotestosterone, pigskin gelatin, bovine serum albumin and merthiolate (thimerosal) were obtained from Sigma Chemical Co.
Ethyl diazoacetate, p-toluenesulfonic acid and p-hydroxyphenylacetic acid were purchased from Aldrich Chemical Co.
Chloramine-T and sodium metabisulfite were from J.T. Baker Co.
Androstenedione, androsterone, 5@-androstenedione, progesterone and estradiol-178 were purchased from Steraloids Inc., Wilton, N.H. RhCI~.BH20 was from Ventron Corporation and HPLC grade acetonitrile was from Burdick & Jackson Laboratories, Muskegon, MI. Other solvents were analytical grade. Steroids used as RIA standards and crossreactants were recrystallized. 11B-hydroxyandrostenedlone (250 mg, 0.84 mmol) was dissolved in dry benzene (40 mL). The catalyst Rh~(O~CCH~) 4 (3 mg), prepared from RhCI~.H20 (11), was then added.
Ethyl @iazdacetate (1.09 gm, 9.51 mmol) ~as added dropwise to the steroid solution.
Additlonal ethyl diazoacetate (2.18 gm, 19.02 mmol) was added 6 hr later, and the reaction stirred at room temperature overnight.
The reaction mixture was poured into H20 (100 mL) and extracted five times with CHC13 (50 mL). The combined organic layer was dried with Na2SO 4 and evaporated invacuo yielding a yellow oil. The oil was chromatographed on a 1.5 x 30 cm silica gel column using a 0 to 2% CH3OH gradient in CHCl~ for elution. A second chromatography step on a 1. The ethyloarboxymethoxy derivative from above (135 mg, 0.346 mmol) was dissolved in CH~OH (10 mL). KOH (6.4 mL of 0.1 ~, 0.70 mmol) was added dropwise at I~°C.
The reaction mixture was then poured into saturated NaC1 solution (200 mL) and made slightly acidic with I HCI. The resulting aqueous mixture was extracted six times with CHCI_ (10 mL). The combined organic phase was dried as above and evaporate~ in vaouo yielding 11B-(carboxymethoxy)-androstene-3,17-dione (II) a~.a clear oil (120 mg, 96%).
IR ( 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDAC) 6100 mg, 1.92 mmol was added, and the mixture stirred for 30 min. Bovine serum albumin (BSA) (200 mg) dissolved in phosphate buffer (0.01 ~, pH 7.8, 20 mL) was added dropwise to the steroid solution which was stirred two days at ambient temperature in the dark.
The solution was dialyzed against 0.05 M NaHCO~ (2 x 2 L) and H~O (4 x 2 L) and lyophilized. The molar ratio--of th~ steroid to protein was found to be 15.0 by spectral analysis (I).
1_~-(o-Hvdroxvnhenvlacetoxv)-4-androstene-~.17-dione (IV). p-Toluenesulfonic acid (160 mg, 0.842 mmol) was dissolved in benzene (30 mL), and the mixture refluxed with a Dean-Stark apparatus for 3 hr to remove H20.
11B-Hydroxyandrostenedione (100 mg, 0.33 mmol) and p-aoetoxyphenylacetic anhydride (I) (200 mg, 0.54 mmol) were added to the benzene solution and the resulting mixture was refluxed for 10 additional min, cooled to room temperature and stirred 48 hr. The reaction mixture was poured into H20 (100 mL) and extracted six times with CHCl~ (30 mL). The combined organic layer was dried as before and evaporated in vacuo yielding a clear oil. The oil was dissolved in methanol (5 mL), 4 drops of saturated NaHCO~ were added, and the mixture stirred fo 1.5 hr. The pH of the solutfon was adjusted to 2.0 with 0.5 ~ HCI and extracted five times with CHCl~ (15 mL).
The chloroform layer was washed twice with H20 (10 mL) ~nd dried. Removal of the solvent left a yellow oil that was purified on a 1. ambient temperature for I mln, the reaction was quenched by the addition of sodium metabisulfite (10 ug, 52.5 nmol) in buffer A (20 uL). Purification of the radioiodinated steroid was done by HPLC. The entire reaction mixture was injected onto an Altech 600-RPA C1g reverse phase column using a Rheodyne injector fitted with a 100 ~E loop.
A Spectro Physics SP8700 pump provided the following mobile phase at a flow rate of I mL/min: 0 to 5 min, an isocratic mixture of 20% acetonitrile in 0.05 ~ potassium formate buffer, pH 4.0; 5 to 80 min, a 20 to 60% gradient of acetonitrile in the formate buffer. The eluted material was collected in a Gilson FC-80 Fraction Collector (I min fractions), and the radioactivity was quantitated with a gamma counter.
Both a monoiodinated (eluting at 65 min) and a diiodinated derivative (77 min) of the steroid were isolated.
The estimated specific activity (12) of the two labels were found to be 3.3 mCi/ug and 5.4 mCi/ug, respectively . The monolodinated label, which was used in the RIA, had a maximal binding (active fraction) of 98% in the presence of exess antibody.
METHODS

Antibody ~
Antibody against the steroid-BSA conjugate III was raised in five Suffolk ewes.
Two milligrams of the conjugate in Freund's complete adjuvant (1.0 mL) was injected intradermally at multiple sites on the flanks of each animal.
Booster injections of 1.0 mg in incomplete Fruend's adjuvant (1.0 mL) were given at weeks 4 and 8. Bleedings were taken at weeks 10 and 11 and the highest titers (dilution of serum needed to bind 50% of the label) were found at week 11.
Serum from sheep #95, which had the best specificity, was used for the RIA.
Radioimmunoassav.
The radioimmunoassay was run as described previously (I) using a 1/50,000 dilution of antisera and 40,000 cpm/tube of label. Crossreactivity studies were done using the method of Thorneycroft et'al (13) .
RESULTS AND DISCUSSION
It was obvious from our previous paper (I) that bridge-binding could be significantly reduced in a RIA for androstenedione by employing heterologous bridges when synthesizing the immunogenic steroidcarrier protein conjugate and the 125I-steroid label.
It was also higher than that reported previously (I) (104 pg vs. 15 or 76 pg).
However, the actual limit of detection (14) is certainly adequate for routine use (200 femtograms (fg)/assay tube). The slope of -1.73 was less than the ideal -2.303 for a logit-log curve but provides a workable assay.
The most obvious improvement was in assay specificity as can be seen in table I which compares the crossreactivity of our current assay using antibody against the 11~-conJugate to the crossreactivltles we reported (I) and those Rao ~_~ al reported (10) using antibodies to the 19-conjugate. (10) reported antlsera (rabbit) to the 19-conjugate with higher specificity than we described (sheep) using the same immunogen (1), the rabbit antibodies are at least 10-fold less specific than the anti-liB-conjugate antibodies. In addition, the anti-116-antlserum also has lower crossreactlvity to testosterone and 5~-dihydrotestosterone than that reported for the rabbit anti-19-conJugate (10).
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The crossreactivity of antl-androstenedione antisera to testosterone and dehydroepiandrosterone is critical since they are present in male human serum samples at concentrations greater than or equal to the amount of androstenedione (19) and would interfere in a RIA.
In conclusion, by using the heterologous bridges we described previously (I), a sensitive and precise steroid radioimmunoassay can be developed. This is evidenced by the assay limit of detection of 200 fg/tube and slope of the inhibition curve of -1.73. In addition, one can produce very specific antibodies by using the 118 position of androstenedione for attachment of the carrier-proteln and labeled functional groups.
